US regulators to weigh controversial peptides backed by RFK Jr

The US Food and Drug Administration has questioned the evidence as demand surges for the compounds promoted for sleep, muscle growth, and anti-ageing.

Published On 22 Jul 2026

Peptides, a class of compounds increasingly marketed as wellness treatments, have exploded in popularity continue reading …